cannabis indica

Dependência — Estimulantes

termo de indexação original: Addiction - Stimulant

O acervo do Cannabis Indica reúne 134 estudos científicos que tocam a condição Dependência — Estimulantes, publicados entre 1993 e 2024. Pela leitura automatizada, 61 (46%) foram classificados como favoráveis, 24 (18%) como inconclusivos e 49 (37%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (64 estudos), seguido de ensaio clínico (32). Os compostos mais presentes são Canabinoide Sintético (não especificado), Tetraidrocanabinol (THC) e Anandamida (AEA). Aparece com frequência ao lado de Dependência Química, Dependência — Cannabis e Dependência — Álcool.

Estudos indexados
134
Período coberto
1993–2024
Favoráveis
61 · 46%
Inconclusivos
24 · 18%
Desfavoráveis
49 · 37%
Termo original
Addiction - Stimulant

O acervo em números

Tipo de estudo

Metanálise64
Ensaio Clínico32
Estudo em Animais21
Metanálise Clínica13
Ensaio Clínico Duplo-Cego3
Estudo Laboratorial1

Direção do resultado

Favorável61
Inconclusivo24
Desfavorável49

Por década

1990s2
2000s6
2010s33
2020s93

134 estudos

Filtrar e buscar no acervo →
  1. 2024

    An intervention based on Well-Being Therapy to prevent alcohol use and other unhealthy lifestyle behaviors among students: a three-arm cluster randomized controlled trial

  2. 2024

    Cannabidiol Therapy for Comorbid Schizophrenia and Addiction: A Guide for Clinical Practice

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisPsicose+6
  3. 2024

    Clinical Variables and Peripheral Biomarkers Associated with Substance-Induced Psychotic Disorder: Differences Related to Alcohol, Cannabis, and Psychostimulant Abuse

  4. 2024

    Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisAnsiedade+3
  5. 2024

    Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis

  6. 2024

    Patterns of Polysubstance Use in Young Black and Latinx Sexual Minority Men and Transgender Women and Its Association with Sexual Partnership Factors: The PUSH Study

  7. 2024

    Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in England

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisPsicose+5
  8. 2023

    A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods

  9. 2023

    A systematic review of brief, freely accessible, and valid self-report measures for substance use disorders and treatment

  10. 2023

    Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+2
  11. 2023

    Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults

  12. 2023

    Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedade+6
  13. 2023

    Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  14. 2023

    Cocaine-Induced Raynaud's Phenomenon: A Case Report

  15. 2023

    Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisPsicose+4
  16. 2023

    Factors associated with suicide in people who use drugs: a scoping review

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+10
  17. 2023

    How are young people’s mental health related to their sexual health and substance use? A systematic review of UK literature

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+4
  18. 2023

    Impact of Harm Reduction Treatment with or without Pharmacotherapy on Polysubstance Use among People Experiencing Homelessness and Alcohol Use Disorder

  19. 2023

    Molecular Insights into GPCR Mechanisms for Drugs of Abuse

  20. 2023

    Retrospective chart review of substance abuse in patients with psychiatric emergencies in an emerging urban county

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — CannabisAnsiedade+8
  21. 2023

    Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial

  22. 2023

    Substance abuse and susceptibility to false memory formation: a systematic review and meta-analysis

  23. 2023

    Substance use and psychotic-like experiences in young people: a systematic review and meta-analysis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+6
  24. 2023

    Systematic review of the efficacy, effectiveness, and cost-effectiveness of stepped-care interventions for the prevention and treatment of problematic substance use

  25. 2023

    The effectiveness of oxytocin for treating substance use disorders:A systematic review of randomized placebo-controlled trials

    InconclusivoMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedade+5
  26. 2023

    Use of psychoactive substances by goods carriage drivers associated with Kerala, India

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDependência — CannabisPsicose+4
  27. 2023

    Using recovery management checkups for primary care to improve linkage to alcohol and other drug use treatment: a randomized controlled trial three month findings

  28. 2022

    #TurntTrending: a systematic review of substance use portrayals on social media platforms

  29. 2022

    A Student Walks into Class … Vignettes to Identify Substance Use Disorder Models of Illness among College Students

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+2
  30. 2022

    A systematic review of substance use and substance use disorder research in Kenya

  31. 2022

    A systematic review of the efficacy, effectiveness and cost-effectiveness of workplace-based interventions for the prevention and treatment of problematic substance use

  32. 2022

    Cannabidiol and substance use disorder: Dream or reality

    FavorávelMetanáliseDependência — OpioidesDependência — Cocaína
  33. 2022

    Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses

    FavorávelEstudo em AnimaisDependência QuímicaAnsiedadeDepressãoÁcido Canabidiólico (CBD-a)+4
  34. 2022

    Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway

    FavorávelEstudo LaboratorialDependência Química
  35. 2022

    Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study

    FavorávelEnsaio ClínicoEsquizofreniaEndocanabinoide (não especificado)
  36. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  37. 2022

    Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies

  38. 2022

    Controlled Trial Examining the Strength-Based Grit Wellbeing and Self-Regulation Program for Young People in Residential Settings for Substance Use

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisAnsiedade+3
  39. 2022

    Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database

  40. 2022

    Digital Help for Substance Users (SU): A Systematic Review

    InconclusivoMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Opioides+3
  41. 2022

    Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply

  42. 2022

    Drugs of Misuse: Focus on Vascular Dysfunction

  43. 2022

    Footshock-Induced Abstinence from Compulsive Methamphetamine Self-administration in Rat Model Is Accompanied by Increased Hippocampal Expression of Cannabinoid Receptors (CB1 and CB2)

  44. 2022

    Gender differences in the association between environment and psychosis

  45. 2022

    Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis

  46. 2022

    Longitudinal study of impact of medication for opioid use disorder on Hamilton Depression Rating Scale

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedade+3
  47. 2022

    Maternal trajectories of cannabis use and young adult cannabis and nicotine dependence

  48. 2022

    MicroRNA Regulation of the Environmental Impact on Adolescent Neurobehavioral Development: A Systematic Review

  49. 2022

    N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials

  50. 2022

    NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches

  51. 2022

    Potential effects of nicotine content in cigarettes on use of other substances

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDependência — Álcool+3
  52. 2022

    Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTetraidrocanabinol (THC)+12
  53. 2022

    Racial and ethnic differences in alcohol, cannabis, and illicit substance use treatment: a systematic review and narrative synthesis of studies done in the USA

  54. 2022

    Resting-state EEG, Substance use and Abstinence After Chronic use: A Systematic Review

  55. 2022

    Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment

  56. 2022

    Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study

  57. 2022

    Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder

  58. 2022

    The endocannabinoid system and drug-associated contextual memories

  59. 2022

    The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use

  60. 2022

    Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals

  61. 2022

    Tina's ParTy line: Polysubstance use patterns in sexual minority men living with HIV who use methamphetamine

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+3
  62. 2021

    [Droghe d'abuso e rene] Drugs of Abuse and the Kidney

  63. 2021

    [Efficacy of psychedelics in psychiatry, a systematic review of the literature]

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedadeAyahuasca+7
  64. 2021

    A 23-year-old man with acute lung injury after using a tetrahydrocannabinol-containing vaping device: a case report

    DesfavorávelMetanáliseInflamaçãoEfeitos Adversos da CannabisNáusea e Vômito+5
  65. 2021

    A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory

  66. 2021

    Cannabidiol enhanced the development of sensitization to the expression of methamphetamine-induced conditioned place preference in male rats

    InconclusivoEstudo em AnimaisDependência QuímicaDependência — CannabisDependência — Cocaína+1
  67. 2021

    Cannabidiol impairs the rewarding effects of methamphetamine: Involvement of dopaminergic receptors in the nucleus accumbens

  68. 2021

    Cannabidiol modulation of hippocampal glutamate in early psychosis

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofrenia
  69. 2021

    Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats

    FavorávelEstudo em AnimaisDependência Química
  70. 2021

    Cannabidiol promotes neurogenesis in the dentate gyrus during an abstinence period in rats following chronic exposure to methamphetamine

    FavorávelEstudo em AnimaisDependência QuímicaEfeitos Adversos do MDMA
  71. 2021

    Cannabis exposure during adolescence: A uniquely sensitive period for neurobiological effects

  72. 2021

    Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers

    FavorávelMetanálise ClínicaDependência — CannabisDependência — OpioidesDependência — Álcool+1
  73. 2021

    Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults

  74. 2021

    Effect of screening, brief intervention and referral to treatment for unhealthy alcohol and other drug use in mental health treatment settings: a randomized controlled trial

  75. 2021

    Engagement patterns with a digital therapeutic for substance use disorders: Correlations with abstinence outcomes

  76. 2021

    Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies

  77. 2021

    Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Cocaína
  78. 2021

    Is marijuana really a gateway drug? A nationally representative test of the marijuana gateway hypothesis using a propensity score matching design

  79. 2021

    Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

  80. 2021

    Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review

    FavorávelMetanáliseDependência QuímicaDependência — CannabisPsicose+4
  81. 2021

    Near-Fatal Spice Intoxication of a Toddler

  82. 2021

    Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)

  83. 2021

    Prevalence, sociodemographic variables, mental health condition, and type of drug use associated with suicide behaviors among people with substance use disorders: a systematic review and meta-analysis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisDepressão+5
  84. 2021

    Psychological and endocannabinoid responses to aerobic exercise in substance use disorder patients

  85. 2021

    Public health impact of daily life triggers of sudden cardiac death: A systematic review and comparative risk assessment

  86. 2021

    Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

  87. 2021

    Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

  88. 2021

    The Impact of Co-occurring Post-traumatic Stress Disorder and Substance Use Disorders on Craving: A Systematic Review of the Literature

  89. 2021

    Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features

    InconclusivoMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+8
  90. 2021

    β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

    FavorávelEstudo em AnimaisDependência Química
  91. 2020

    Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats

    FavorávelEstudo em AnimaisDependência Química
  92. 2020

    Prevalence of Common Mental Disorders in South Asia: A Systematic Review and Meta-Regression Analysis

  93. 2020

    Risk Management in First Aid for Acute Drug Intoxication

  94. 2019

    Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD

    FavorávelMetanálise ClínicaDependência QuímicaTDA e TDAHTHC:CBD Farmacêutico
  95. 2019

    Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms

    InconclusivoMetanáliseDependência QuímicaDependência — Cocaína
  96. 2019

    Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC–MS and LC–MS-MS analysis

  97. 2019

    Prevention of Alcohol and Other Drug Overuse Among Nightclub Patrons: A Randomized Trial of a Group-Based Mobile Intervention at Nightclubs

  98. 2019

    The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — CannabisPsicose
  99. 2018

    Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats

    FavorávelEstudo em AnimaisDependência QuímicaInsônia e Distúrbios do Sono
  100. 2018

    Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats

    FavorávelEstudo em AnimaisDependência Química
  101. 2017

    Substance Use Among Homeless Individuals With Schizophrenia and Bipolar Disorder

    DesfavorávelMetanáliseDependência — CannabisPsicoseDependência — Opioides+4
  102. 2017

    The social exigencies of the gateway progression to the use of illicit drugs from adolescence into adulthood

  103. 2016

    A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+3
  104. 2016

    Cannabidiol Counteracts Amphetamine-Induced Neuronal And Behavioral Sensitization Of The Mesolimbic Dopamine Pathway Through A Novel MTOR/p70S6 Kinase Signaling Pathway

    FavorávelEstudo em AnimaisPsicoseEsquizofrenia
  105. 2016

    Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes

  106. 2016

    Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

    InconclusivoMetanáliseDependência — CannabisDependência — OpioidesHepatite+1
  107. 2016

    Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation.

  108. 2016

    Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence

  109. 2016

    Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers

  110. 2016

    Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251

  111. 2015

    A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial

  112. 2015

    Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

    FavorávelMetanáliseDorDependência QuímicaDependência — Cannabis+16
  113. 2015

    MDMA, cannabis, and cocaine produce acute dissociative symptoms

    DesfavorávelEnsaio ClínicoDependência QuímicaEfeitos Adversos da CannabisAnsiedade+7
  114. 2015

    The association between impulsivity and alcohol/drug use among prison inmates

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+5
  115. 2014

    Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

  116. 2014

    Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system

  117. 2014

    Δ9-tetrahydrocannabinol Prevents Methamphetamine-induced Neurotoxicity

    FavorávelEstudo em AnimaisDependência QuímicaTetraidrocanabinol (THC)
  118. 2013

    Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors

    InconclusivoEstudo em AnimaisDependência QuímicaEfeitos Adversos do MDMA
  119. 2013

    Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults

  120. 2013

    Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+4
  121. 2011

    Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence

    InconclusivoMetanáliseDependência QuímicaPsicoseEsquizofrenia
  122. 2011

    Does change in cannabis use in established psychosis affect clinical outcome?

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisDependência — CannabisPsicose+4
  123. 2011

    Involvement of the endocannabinoid system in reward processing in the human brain

  124. 2010

    Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis.

  125. 2010

    Effects of cannabinoid-receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys

  126. 2010

    Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Opioides+1
  127. 2006

    A meta-analysis of negative symptoms in dual diagnosis schizophrenia

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Opioides+3
  128. 2005

    A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia

  129. 2004

    Effect Of Low Doses Of Delta9-tetrahydrocannabinol And Cannabidiol On The Extinction Of Cocaine-induced And Amphetamine-induced Conditioned Place Preference Learning In Rats

  130. 2004

    Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.

    FavorávelEstudo em AnimaisDependência QuímicaCanabinoides Sintéticos SR-x
  131. 2004

    Neurocognitive Performance Of Methamphetamine Users Discordant For History Of Marijuana Exposure

    InconclusivoMetanáliseDependência Química
  132. 2002

    Motivational interviewing among psychiatric in-patients with substance use disorder

  133. 1999

    A validity study of the SSAGA--a comparison with the SCAN

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Álcool+2
  134. 1993

    Characterization of cannabidiol-mediated cytochrome P450 inactivation.

    FavorávelEstudo em Animais

Continue por aqui

Perguntas frequentes

Quantos estudos sobre dependência — estimulantes estão indexados no acervo?
São 134 estudos, publicados entre 1993 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 64 · Ensaio Clínico: 32 · Estudo em Animais: 21 · Metanálise Clínica: 13 · Ensaio Clínico Duplo-Cego: 3 · Estudo Laboratorial: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 61 favoráveis, 24 inconclusivos e 49 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Dependência — Estimulantes — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/dependencia-estimulantes/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Dependência — Estimulantes — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/dependencia-estimulantes/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.